AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore
Predicta Biosciences at AMP 2026
Nov 10–14, 2026 Seattle, WA ~2k attendees Website
Predicta Biosciences brings 1 presentation to AMP 2026 in Seattle. Its session covers next-generation sequencing on Roche's AXELIOS 1 platform. The company's genome sequencing test on blood or bone marrow diagnoses and guides treatment of multiple myeloma.
| Organization | AMP 2026 Attendance |
|---|---|
Predicta Biosciences Cambridge, MA | |
Blood-cancer diagnostics company whose genome sequencing test on blood or bone marrow diagnoses and guides treatment of multiple myeloma. | Workshop Wed, Nov 11 12:00pm–12:50pm Next-Generation Sequencing with Roche’s AXELIOS 1 Platform Roche's AXELIOS 1 sequencer and its expansion-based chemistry, covering accuracy, read length and run flexibility. |
Find decision makers at Predicta Biosciences
Tell us what you sell and we’ll find the people at Predicta Biosciences most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction